Beijing Tiantan Biological Products Corp. Ltd.

Beijing Tiantan Biological Products Corp. saw a rise in stock price on May 29, 2026, contrasting with a decline in the China Shanghai Composite. Despite recent gains, the company has faced significant long-term challenges, including a notable drop in net sales and a declining market capitalization in the competitive pharmaceuticals sector.

Beijing Tiantan Biological Products Corp. saw a notable increase today, contrasting with a decline in the broader market. However, the company faces significant long-term challenges, including a substantial decline in stock value over the past year and a reported drop in net sales, alongside negative operating cash flow.

Beijing Tiantan Biological Products Corp. faced significant stock declines, with a 4.64% drop today and a 25.83% decrease over the past year. Financial metrics reveal a 24.69% decline in net sales and negative operating cash flow, indicating ongoing challenges in the pharmaceuticals and biotechnology sector.

Beijing Tiantan Biological Products Corp. has faced significant stock declines, with a year-to-date drop of 5.08% and a 24.12% decrease over the past year. Financial metrics reveal challenges, including a 24.69% fall in net sales and negative operating cash flow, while the company retains a market capitalization of CNY 32,231 million.